You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent Glioblastoma Multiforme

Showing 1 - 25 of 9,065
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

Recruiting
  • Recurrent Glioblastoma Multiforme
  • SNC-109 CAR-T Cells
  • Beijing, China
    Chinese PLA General Hospital
May 11, 2023

Brain and Nervous System Trial in Palo Alto (B7-H3CART)

Recruiting
  • Brain and Nervous System
  • Palo Alto, California
    Stanford Cancer Institute
Jul 22, 2022

Glioblastoma Multiforme Trial in Australia, United States (Nativis Voyager RFE Therapy)

Completed
  • Glioblastoma Multiforme
  • Nativis Voyager RFE Therapy
  • Birmingham, Alabama
  • +12 more
Jan 31, 2023

Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular

Completed
Has Results
  • Gliosarcoma
  • Recurrent Glioblastoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 5, 2022

Recurrent Glioblastoma Multiforme Trial in Sao Paulo (Stereotactic hypofractionated RT 5x5Gy, Stereotactic hypofractionated RT

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • Stereotactic hypofractionated RT 5x5Gy
  • Stereotactic hypofractionated RT 5x7Gy
  • Sao Paulo, SP, Brazil
    Hospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Recurrent Glioblastoma Multiforme(GBM) Trial in Houston (ACT001, ACT001 + Pembrolizumab)

Recruiting
  • Recurrent Glioblastoma Multiforme(GBM)
  • Houston, Texas
    UT MD Anderson Cancer Center, Dept of Neuro-Oncology
Nov 12, 2021

Glioblastoma, Brain Tumors Trial in Gainesville, Saint Louis (device, procedure, genetic)

Terminated
  • Glioblastoma
  • Brain Neoplasms
  • NovoTTF-100A
  • +2 more
  • Gainesville, Florida
  • +1 more
Nov 19, 2021

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

Recruiting
  • Glioblastoma
  • +3 more
  • Radiation: Intra-operative Radiation Therapy - IORT
  • +2 more
  • Santa Monica, California
    Providence Saint John's Health Center
Jul 14, 2022

Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Recurrent Glioblastoma
  • Pitavastatin calcium
  • Rotterdam, Netherlands
    Erasmus MC
Aug 3, 2023

Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

Not yet recruiting
  • Recurrent Glioblastoma
  • +2 more
  • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
  • Charlottesville, Virginia
    University of Virginia
Sep 10, 2023

Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • +2 more
  • M032 (NSC 733972)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 26, 2022

Glioblastoma, Glioblastoma Multiforme Trial (APG-157)

Available
  • Glioblastoma
  • Glioblastoma Multiforme
  • (no location specified)
Sep 19, 2022

GBM, Glioblastoma Multiforme, Gliosarcoma Trial in Providence, Dallas (PSMA ADC)

Completed
Has Results
  • GBM
  • +2 more
  • PSMA ADC
  • Providence, Rhode Island
  • +1 more
Nov 22, 2021

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Recurrent Glioblastoma Trial in Portland (TVI-Brain 1)

Available
  • Recurrent Glioblastoma
  • TVI-Brain 1
  • Portland, Oregon
    Providence St. Vincent Medical Center
Jun 28, 2023

Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

Active, not recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • Radiation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor Trial in Cleveland (AutoLITT system)

Completed
  • Brain Tumor
  • +5 more
  • AutoLITT system
  • Cleveland, Ohio
  • +1 more
Aug 23, 2021

Glioblastoma Trial in Saint Louis (device, drug, other)

Completed
  • Glioblastoma
  • MRI-guided Laser Heat Ablation (MLA)
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 26, 2021

Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • CHM-1101 CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Dec 19, 2022

Glioma, Glioblastoma Multiforme Trial in Rochester, Omaha (APG-157)

Not yet recruiting
  • Glioma
  • Glioblastoma Multiforme
  • Rochester, Minnesota
  • +1 more
Aug 23, 2023

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

Glioblastoma Multiforme, Glioblastoma, Adult, Glioblastoma Trial in Amsterdam, Groningen, Nijmegen (Sunitinib, Lomustine)

Recruiting
  • Glioblastoma Multiforme
  • +4 more
  • Amsterdam, Netherlands
  • +2 more
Apr 14, 2021